US approves honeybee vaccine against hive-destroying disease

日本 ニュース ニュース

US approves honeybee vaccine against hive-destroying disease
日本 最新ニュース,日本 見出し
  • 📰 TheRegister
  • ⏱ Reading Time:
  • 66 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 61%

Uncle Sam OKs vaccine that protects honeybees against hive-destroying bacterium

Yay, we got a B for maths. Literally, a bee: Little nosy nectar nerds smart enough to add, abstract numbers

The vaccine is mixed into queen feed, which is consumed by worker bees who then spread it into the royal jelly, which is fed to the queen bee. With the vaccine now deposited in her ovaries, the developing larvae have immunity as they hatch.

The plan is to sell the vaccine to commercial beekeeping operations, on which the US in particular is unusually dependent to help support its crop pollination. Hives are regularly transported across the country as part of farming processes for the kind of fruit, berries and nuts that you find in supermarkets. Ironically, this exposes the bees to stress and diseases.

"We are committed to providing innovative solutions to protect our pollinators and promote sustainable agriculture," said Dr Annette Kleiser, CEO of Dalan Animal Health."Global population growth and changing climates will increase the importance of honeybee pollination to secure our food supply. Our vaccine is a breakthrough in protecting honeybees. We are ready to change how we care for insects, impacting food production on a global scale.

Manufactured by Iowa-based Diamond Animal Health, a wholly owned subsidiary of Heska, the vaccine is expected to be available from 2023, with the USDA conditional license granted in the first instance for two years.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

TheRegister /  🏆 67. in UK

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Comparison of the Journey II bicruciate stabilised (JII-BCS) and GENESIS II total knee arthroplasty for functional ability and motor impairment: the CAPAbility, blinded, randomised controlled trialObjectives To determine if a newer design of total knee replacement (TKR) (Journey II BCS) produces superior patient-reported outcomes scores and biomechanical outcomes than the older, more established design (Genesis II). Setting Patients were recruited from an NHS University Hospital between July 2018 and October 2019 with surgery at two sites. Biomechanical and functional capacity measurements were at a University Movement and Exercise Laboratory. Participants 80 participants undergoing single-stage TKR. Interventions Patients were randomised to receive either the Journey II BCS (JII-BCS) or Genesis II TKR. Primary and secondary outcome measures Primary outcome was the Oxford Knee Score (OKS), at 6 months. Secondary outcomes were: OKS Activity and Participation Questionnaire, EQ-5D-5L and UCLA Activity scores, Timed Up and Go Test, 6 min walk test, lower limb kinematics and lower limb muscle activity during walking and balance. Results This study found no difference in the OKS between groups. The OKS scores for the JII-BCS and Genesis II groups were mean (SD) 42.97 (5.21) and 43.13 (5.20) respectively, adjusted effect size 0.35 (-2.01,2.71) p=0.771 In secondary outcome measures, the Genesis II group demonstrated a significantly greater walking range-of-movement (50.62 (7.33) vs 46.07 (7.71) degrees, adjusted effect size, 3.14 (0.61,5.68) p=0.02) and higher peak knee flexion angular velocity during walking (mean (SD) 307.69 (38.96) vs 330.38 (41.40) degrees/second, adjusted effect size was 21.75 (4.54,38.96), p=0.01) and better postural control (smaller resultant centre of path length) during quiet standing than the JII-BCS group (mean (SD) 158.14 (65.40) vs 235.48 (176.94) mm, adjusted effect size, 59.91 (–105.98, –13.85) p=0.01.). Conclusions In this study population, the findings do not support the hypothesis that the Journey II BCS produces a better outcome than the Genesis II for the primary outcome of the OKS at 6 months after surgery. Trial registration num
続きを読む »

India OKs $2.3 Billion To Become Global Green Hydrogen HubIndia OKs $2.3 Billion To Become Global Green Hydrogen HubThe funding decision will support production, use, and exports of green hydrogen for the nascent industry.
続きを読む »

What ITV’s farcical drama Stonehouse left out about my great-uncle’s complex lifeWhat ITV’s farcical drama Stonehouse left out about my great-uncle’s complex lifeWhat ITV’s farcical drama Stonehouse left out about my great-uncle’s complex life 💬 via ipaperviews
続きを読む »

5 Signs Your 'Dry January' Should Maybe Be A Permanent Thing5 Signs Your 'Dry January' Should Maybe Be A Permanent ThingIs a month without alcohol hard – or can you see glaring benefits? Either way, here's how to make it stick.
続きを読む »

Hooray, you can finally actually get a PS5 (maybe)Hooray, you can finally actually get a PS5 (maybe)It could be the time to get a PS5 – now that they're actually available.
続きを読む »

FTX boss Sam Bankman-Fried pleads not guilty on 8 chargesFTX boss Sam Bankman-Fried pleads not guilty on 8 chargesFTX boss Sam Bankman-Fried pleads not guilty on eight charges
続きを読む »



Render Time: 2025-04-02 06:51:18